Swindells S, Andrade-Villanueva JF, Richmond GJ, et al. Long-acting cabotegravir + rilpivirine as maintenance therapy: ATLAS week 48 results. CROI 2019, abstract 139.
Raltegravir geschikt alternatief in lageloonlanden
mei 2017 | HIV
jun 2024 | Niertransplantatie, Stamceltransplantatie, Virale infecties